Safety and immunogenicity of a ChAd155-vectored RSV vaccine (ChAd155-RSV) in healthy RSV-seropositive children 12-23 months of age.
Javier Díez-DomingoXavier Sáez-LlorensMiguel A Rodriguez-WeberCristina EpalzaArchana ChatterjeeCheng-Hsun ChiuChien-Yu LinAndrea A BerryFederico Martinón-TorresFernando Baquero-ArtigaoJoanne M LangleyJosé T Ramos AmadorJoseph B DomachowskeLi-Min HuangNan-Chang ChiuSusanna EspositoPhilippe MorisThi Lien-Anh NguyenVanja NikicWayne WooYingjun ZhouIlse DieussaertAmanda LeachAntonio Gonzalez LopezNicolas VanhouttePublished in: The Journal of infectious diseases (2022)
clinicaltrials.gov NCT02927873, URL: https://www.clinicaltrials.gov/ct2/show/NCT02927873.